Zhongzhi Pharmaceutical Holdings Ltd operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhongzhi Pharmaceutical Holdings Ltd with three other
drug stores in Asia:
Apex Healthcare Bhd
sales of 688.79 million Malaysian Ringgits [US$163.03 million]
of which 91%
was Wholesale and Distribution),
Shanghai No.1 Pharmacy Co Ltd
(1.24 billion Chinese Renmimbi [US$178.08 million]
of which 59%
was Pharmaceutical Retail), and
Great Tree Pharmacy Co Ltd
based in TAIWAN
(6.60 billion Taiwanese Dollars [US$224.85 million]
of which 100%
was Drugs,cosmetics and healthcare).
During the year ended December of 2019, sales at
Zhongzhi Pharmaceutical Holdings Ltd were HK$1.52 billion (US$196.64 million).
increase of 12.7%
versus 2018, when the company's sales were HK$1.35 billion.
This was the fifth consecutive year of sales increases at Zhongzhi Pharmaceutical Holdings Ltd
(and since 2014, sales have increased a total of 104%).
Sales of Pharmaceutical Manufacturing saw an increase
14.0% in 2019, from
HK$750.25 million to HK$855.45 million.